MicroRNA-377 inhibits non-small-cell lung cancer through targeting AEG-1

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Non-small-cell lung cancer (NSCLC) remains a leading cause of cancer mortality worldwide.
• MicroRNAs (miRNAs) are implicated in cancer development, but the specific role of microRNA-377 (miR-377) in NSCLC is unclear.
• Understanding miR-377's function is crucial for developing novel NSCLC therapeutic strategies.

Purpose of the Study:

• To investigate the role of miR-377 in the pathogenesis of NSCLC.
• To identify and validate the target genes of miR-377 in NSCLC.
• To explore the potential of miR-377 as a therapeutic target for NSCLC.

Main Methods:

• Quantitative real-time PCR to assess miR-377 expression in NSCLC tissues and cell lines.
• Cell viability, proliferation, migration, and invasion assays to evaluate the functional impact of miR-377.
• Bioinformatics analysis and dual-luciferase reporter assays to identify and confirm astrocyte elevated gene-1 (AEG-1) as a direct target of miR-377.
• Western blotting to assess AEG-1 protein levels following miR-377 overexpression.

Main Results:

• miR-377 expression was significantly reduced in NSCLC tissues and cell lines compared to normal controls.
• Overexpression of miR-377 suppressed NSCLC cell viability, proliferation, migration, and invasion.
• Astrocyte elevated gene-1 (AEG-1), an established oncogene, was identified as a direct target of miR-377.
• miR-377 overexpression decreased AEG-1 protein levels, but not mRNA levels, indicating post-transcriptional regulation.
• Restoration of AEG-1 expression reversed the inhibitory effects of miR-377 on NSCLC cells.

Conclusions:

• miR-377 functions as a tumor suppressor in NSCLC by inhibiting cell proliferation, migration, and invasion.
• The tumor-suppressive activity of miR-377 is mediated, at least in part, through the downregulation of AEG-1.
• miR-377 represents a promising therapeutic target for the treatment of NSCLC.